<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Like the <z:chebi fb="0" ids="2719,48432">angiotensin II</z:chebi> type 1 receptor blocker, endogenous <z:chebi fb="0" ids="50114">estrogen</z:chebi> (17β-<z:chebi fb="1" ids="23965">estradiol</z:chebi>) is neuroprotective against <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo>; its effects are thought to be mediated by <z:chebi fb="0" ids="50114">estrogen</z:chebi> receptors (ERs) </plain></SENT>
<SENT sid="1" pm="."><plain>To verify the role of ERs and the brain renin-angiotensin system in <z:chebi fb="0" ids="50114">estrogen</z:chebi>-deficient rats with <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> induced by middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp>, we compared rats subjected to oophorectomy (OVX(+)) with sham-oophorectomized rats (OVX(-)) and OVX(+) rats treated with 0.3 or 3.0 mg/kg of <z:chebi fb="0" ids="48416">olmesartan</z:chebi> for 2 weeks before middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>Independent of the blood pressure, the cortical <z:mpath ids='MPATH_124'>infarct</z:mpath> volume was larger in OVX(+) than in OVX(-) rats </plain></SENT>
<SENT sid="3" pm="."><plain>It was smaller in <z:chebi fb="0" ids="48416">olmesartan</z:chebi>-pretreated OVX(+) rats </plain></SENT>
<SENT sid="4" pm="."><plain>The expression of ERα in the peri-<z:mpath ids='MPATH_124'>infarct</z:mpath> region was correlated with the reduction of cortical <z:mpath ids='MPATH_124'>infarct</z:mpath> but not that of ERβ or G protein-coupled <z:chebi fb="0" ids="50114">estrogen</z:chebi> receptor </plain></SENT>
<SENT sid="5" pm="."><plain><z:chebi fb="0" ids="48416">Olmesartan</z:chebi> prevented ERα downregulation in the cortical peri-<z:mpath ids='MPATH_124'>infarct</z:mpath> area, without affecting ERβ or G protein-coupled <z:chebi fb="0" ids="50114">estrogen</z:chebi> receptor </plain></SENT>
<SENT sid="6" pm="."><plain><z:chebi fb="0" ids="48416">Olmesartan</z:chebi> also increased <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression of angiotensin-converting enzyme 2, Bcl-2, and Bcl-xL and reduced <z:chebi fb="0" ids="2719,48432">angiotensin II</z:chebi> and cleaved caspase 3 </plain></SENT>
<SENT sid="7" pm="."><plain>These effects were augmented by <z:chebi fb="0" ids="48416">olmesartan</z:chebi> and abolished by the ER inhibitor </plain></SENT>
<SENT sid="8" pm="."><plain>In OVX(+) rats treated with the ERα <z:chebi fb="4" ids="48705">agonist</z:chebi> alone, the <z:mpath ids='MPATH_124'>infarct</z:mpath> size was decreased, and the neuroprotective genes were upregulated </plain></SENT>
<SENT sid="9" pm="."><plain>These findings suggest that the transactivation of neuroprotective genes and the reduction in brain <z:chebi fb="0" ids="2719,48432">angiotensin II</z:chebi> are ERα dependent and that this may augment neuroprotection together with an <z:chebi fb="0" ids="2719,48432">angiotensin II</z:chebi> type 1 receptor blockade by <z:chebi fb="0" ids="48416">olmesartan</z:chebi> </plain></SENT>
<SENT sid="10" pm="."><plain>We present the new insight that the activation of ERα independent of <z:chebi fb="0" ids="50114">estrogen</z:chebi> contributes at least partly to limiting cerebral ischemic damage </plain></SENT>
</text></document>